D. Colnot

发表

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.

W. Oyen, G. Snow, G. V. van Dongen, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

G. Snow, G. V. van Dongen, R. de Bree, 2003, Cancer Immunology, Immunotherapy.

Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study.

G. Snow, G. V. van Dongen, R. de Bree, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

16 Bradycardia in Children During General Anaesthesia

J. Hermanides, J. Lens, J. Quak, 2017 .

Bradycardia in Children During General Anaesthesia

J. Hermanides, J. Lens, J. Quak, 2012 .

Bioactive glass (S53P4) as obliteration material in subtotal petrosectomy: initial experience

J. Buwalda, D. Colnot, J. Lindeboom, 2022, The Journal of Laryngology & Otology.

Molecular diagnosis of head and neck cancer.

P. V. van Diest, J. Westerga, R. Brakenhoff, 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Clinical Significance of Micrometastatic Cells Detected by E48 (Ly-6D) Reverse Transcription-Polymerase Chain Reaction in Bone Marrow of Head and Neck Cancer Patients

C. R. Leemans, G. Snow, G. V. van Dongen, 2004, Clinical Cancer Research.

Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients

C. Orelio, J. Quak, P. Borggreven, 2017, European Archives of Oto-Rhino-Laryngology.

[Hypoxaemia and bradycardia in children during guillotine adenotonsillectomy without intubation].

I. Siccama, J. Quak, P. Houweling, 2010, Nederlands tijdschrift voor geneeskunde.

Lyme Disease Associated With Sudden Sensorineural Hearing Loss: Case Report and Literature Review

S. Thijsen, N. Peeters, B. (. Y. van der Kolk, 2013, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience

G. Snow, G. V. van Dongen, R. de Bree, 2001, Head & neck.

Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration

S. Mes, J. Quak, P. Borggreven, 2022, European Archives of Oto-Rhino-Laryngology.

Mastoid Obliteration Using S53P4 Bioactive Glass in Cholesteatoma Surgery: A 10-Year Single-Center Experience in 173 Adult Patients with Long-Term Magnetic Resonance Imaging Controlled Follow-up

S. Mes, J. Quak, P. Borggreven, 2022, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery

C. Orelio, J. Quak, P. Borggreven, 2017, Acta oto-laryngologica.

The value of non echo planar, diffusion-weighted magnetic resonance imaging for the detection of residual or recurrent middle-ear cholesteatoma

K. V. van Everdingen, S. Velthuis, J. Quak, 2014, The Journal of Laryngology & Otology.

Practical applicability of the STAMCO and ChOLE classification in cholesteatoma care

S. Kramer, J. Buwalda, J. Koopman, 2020, European Archives of Oto-Rhino-Laryngology.

Head and neck squamous cell carcinoma: US-guided fine-needle aspiration of sentinel lymph nodes for improved staging--initial experience.

G. Snow, J. Castelijns, R. Brakenhoff, 2001, Radiology.

In response to letter to the editor: Lyme disease associated with sudden sensorineural hearing loss: case report and literature review.

N. Peeters, D. Colnot, 2013, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Imaging and analysis of perivascular nerves in human mesenteric and coronary arteries: a comparison between epi-fluorescence and confocal microscopy

R. Bleys, J. Buwalda, T. Cowen, 1997, Journal of Neuroscience Methods.

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.

G. Snow, G. V. van Dongen, A. van Lingen, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

18F-NaF PET/CT imaging of bone formation induced by bioactive glass S53P4 after mastoid obliteration

P. J. Hagen, J. Quak, A. Timmermans, 2019, European Journal of Hybrid Imaging.

Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy.

G. Snow, G. V. van Dongen, R. de Bree, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[Cholesteatoma: rare, but can have serious consequences].

J. Quak, P. Borggreven, D. Colnot, 2020, Nederlandsch tijdschrift voor geneeskunde.

Lymphoscintigraphy and ultrasound-guided fine needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients.

G. Snow, J. Castelijns, R. Brakenhoff, 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.

P. Huijgens, J. Roos, A. Lingen, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients

C. Orelio, J. Quak, P. Borggreven, 2017, European Archives of Oto-Rhino-Laryngology.